Related content

Genetic and expressional variations of APEX1 are associated with increased risk of head and neck cancer

By Mahjabeen Ishrat   Baig Ruqia Mehmood   Sabir Maimoona   Kayani Mahmood Akhtar  

Mutagenesis, Vol. 28, Iss. 2, 2013-03 ,pp. : 213-218

Oxford University Press

Access to resources Recommend Favorite

Zalutumumab in head and neck cancer

By Schick Ulrike   Gujral Dorothy M   Richards Tom M   Harrington Kevin J   Nutting Christopher M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

Immune alterations and immunotherapy prospects in head and neck cancer

By Varilla Vincent  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1241-1256

Informa Healthcare

Access to resources Recommend Favorite

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J   Lui Vivian Wai Yan   Grandis Jennifer Rubin  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite

Selenium and immunocompetence in patients with head and neck cancer

By Kiremidjian-Schumacher L.   Roy M.   Glickman R.   Schneider K.   Rothstein S.   Cooper J.   Hochster H.   Kim M.   Newman R.  

Biological Trace Element Research, Vol. 73, Iss. 2, 2000-02 ,pp. : 97-111

Humana Press, Inc

Access to resources Recommend Favorite